Prometheus Biosciences, Inc., (RXDX) Stock Charts RXDX Home News Ratings Charts Warning: This security is no longer trading. Roche has completed deal to acquire Ignyta, Inc. Prometheus Biosciences, Inc., (RXDX): $199.92 0.18 (+0.09%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum NR Stability NR Sentiment Get Rating Quality NR Add RXDX to Watchlist Sign Up Industry: Biotech Industry NR Ranked in industry See All 'A' Rated Buy Stocks Prometheus Biosciences, Inc., (RXDX) Performance Graph for POWR Ratings Prometheus Biosciences, Inc., (RXDX) Interactive Chart RXDX Chart by TradingView Prometheus Biosciences, Inc., (RXDX) Ratings History Chart Free access to the full ratings history for RXDX. Sign up now! Most Popular Stories View All • Stock Investors: Are You “Fed Up”? • 3 Streaming Giants Ending the Year on a High Note • 3 Gold Miners Glittering with High Upsides • 3 Digital Entertainment Companies Capitalizing on Streaming Growth • Is the Stock Market in a Rolling Correction? View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
